[
    {
        "text": "(upbeat music)",
        "start": 1.087,
        "duration": 2.583
    },
    {
        "text": "It's a huge honor",
        "start": 8.51,
        "duration": 1.16
    },
    {
        "text": "to have been selected for the Talented Twelve.",
        "start": 9.67,
        "duration": 1.869
    },
    {
        "text": "I'm extremely grateful, you know,",
        "start": 11.539,
        "duration": 1.591
    },
    {
        "text": "to have been selected for the people that nominated me",
        "start": 13.13,
        "duration": 2.001
    },
    {
        "text": "and who have helped me along the way.",
        "start": 15.131,
        "duration": 2.897
    },
    {
        "text": "So, before I get into the chemistry",
        "start": 18.028,
        "duration": 1.822
    },
    {
        "text": "I just want to give a quick overview of who I am.",
        "start": 19.85,
        "duration": 2.16
    },
    {
        "text": "I'm a native of Iowa.",
        "start": 22.01,
        "duration": 1.36
    },
    {
        "text": "Born 34 years ago, in beautiful Iowa.",
        "start": 23.37,
        "duration": 3.62
    },
    {
        "text": "So, after high school, I didn't really know what to do,",
        "start": 26.99,
        "duration": 1.43
    },
    {
        "text": "so, I started at community college",
        "start": 28.42,
        "duration": 1.46
    },
    {
        "text": "and then transferred to the University of Northern Iowa",
        "start": 29.88,
        "duration": 3.09
    },
    {
        "text": "where I was initially pre-med.",
        "start": 32.97,
        "duration": 1.72
    },
    {
        "text": "And it was the Organic Chemistry class that I took",
        "start": 34.69,
        "duration": 1.41
    },
    {
        "text": "that really sparked my interest",
        "start": 36.1,
        "duration": 1.29
    },
    {
        "text": "and led me to switch my career to chemistry.",
        "start": 37.39,
        "duration": 2.24
    },
    {
        "text": "And I was fortunate enough to do",
        "start": 39.63,
        "duration": 1.03
    },
    {
        "text": "some really nice undergraduate research with Martin Chen,",
        "start": 40.66,
        "duration": 3.55
    },
    {
        "text": "who is an excellent advisor,",
        "start": 44.21,
        "duration": 1.25
    },
    {
        "text": "and he encouraged me to do a PhD.",
        "start": 45.46,
        "duration": 3.09
    },
    {
        "text": "So, I followed his sage advice",
        "start": 48.55,
        "duration": 1.95
    },
    {
        "text": "and I did my PhD with John Hartwig",
        "start": 50.5,
        "duration": 1.95
    },
    {
        "text": "at the University of California, Berkeley.",
        "start": 52.45,
        "duration": 1.91
    },
    {
        "text": "I did various things,",
        "start": 54.36,
        "duration": 1.26
    },
    {
        "text": "mostly around fluorine",
        "start": 55.62,
        "duration": 2.06
    },
    {
        "text": "and fluorinated functional groups with copper.",
        "start": 57.68,
        "duration": 3.48
    },
    {
        "text": "And it was during my PhD,",
        "start": 61.16,
        "duration": 0.85
    },
    {
        "text": "that I also became interested in process chemistry,",
        "start": 62.01,
        "duration": 2.01
    },
    {
        "text": "specifically in the pharmaceutical sector.",
        "start": 64.02,
        "duration": 2.01
    },
    {
        "text": "I got a little taste of that",
        "start": 66.03,
        "duration": 1.59
    },
    {
        "text": "by developing a multi-kilo scale synthesis",
        "start": 67.62,
        "duration": 2.18
    },
    {
        "text": "of what John turned,",
        "start": 69.8,
        "duration": 2.29
    },
    {
        "text": "the Trifluoromethylator",
        "start": 72.09,
        "duration": 0.833
    },
    {
        "text": "which is shown in the top right there.",
        "start": 72.923,
        "duration": 1.114
    },
    {
        "text": "So, this was commercialized through several vendors.",
        "start": 74.037,
        "duration": 3.456
    },
    {
        "text": "And then in 2015,",
        "start": 78.33,
        "duration": 1.88
    },
    {
        "text": "I was fortunate enough to land my dream job",
        "start": 80.21,
        "duration": 1.93
    },
    {
        "text": "and start as a process chemist at Merck",
        "start": 82.14,
        "duration": 1.81
    },
    {
        "text": "in Rahway, New Jersey.",
        "start": 83.95,
        "duration": 1.6
    },
    {
        "text": "Now, where I've been ever since.",
        "start": 85.55,
        "duration": 0.96
    },
    {
        "text": "And really the highlight of my career",
        "start": 86.51,
        "duration": 1.63
    },
    {
        "text": "has been the work I did last year and this year",
        "start": 88.14,
        "duration": 3.558
    },
    {
        "text": "as a Process Chemistry lead for molnupiravir",
        "start": 91.698,
        "duration": 2.532
    },
    {
        "text": "which is Merck's oral antiviral for COVID-19,",
        "start": 94.23,
        "duration": 2.94
    },
    {
        "text": "which I'll get to at the end of the talk.",
        "start": 97.17,
        "duration": 2.7
    },
    {
        "text": "You know, so as a process chemist",
        "start": 99.87,
        "duration": 1.23
    },
    {
        "text": "in the pharmaceutical sector,",
        "start": 101.1,
        "duration": 0.96
    },
    {
        "text": "the types of molecules that I work with",
        "start": 102.06,
        "duration": 1.45
    },
    {
        "text": "on a day-to-day basis look like the one shown here.",
        "start": 103.51,
        "duration": 2.4
    },
    {
        "text": "So, there's a lot of Lewis basic heteroatoms,",
        "start": 105.91,
        "duration": 2.15
    },
    {
        "text": "their sensitive functionality",
        "start": 108.06,
        "duration": 1.41
    },
    {
        "text": "and complex physical chemical properties.",
        "start": 109.47,
        "duration": 2.18
    },
    {
        "text": "And a few functional groups that are particularly prevalent",
        "start": 111.65,
        "duration": 2.31
    },
    {
        "text": "are phenols, pyridines, and sulfonamides.",
        "start": 113.96,
        "duration": 2.87
    },
    {
        "text": "So, you know, I'm interested in not only methods",
        "start": 116.83,
        "duration": 3.28
    },
    {
        "text": "to access these functional groups,",
        "start": 120.11,
        "duration": 1.86
    },
    {
        "text": "but also manipulate them in complex settings,",
        "start": 121.97,
        "duration": 1.9
    },
    {
        "text": "such as the ones shown here.",
        "start": 123.87,
        "duration": 1.91
    },
    {
        "text": "For example, how could we functionalize",
        "start": 125.78,
        "duration": 0.833
    },
    {
        "text": "a pyridine in this setting",
        "start": 126.613,
        "duration": 1.797
    },
    {
        "text": "or functionalize a sulfonamide or make a phenol,",
        "start": 128.41,
        "duration": 2.99
    },
    {
        "text": "sorry, I guess my pointer doesn't work.",
        "start": 131.4,
        "duration": 2.13
    },
    {
        "text": "Make the, you know, phenols shown in the bottom right.",
        "start": 133.53,
        "duration": 2.72
    },
    {
        "text": "And well, I'll tell you about first is",
        "start": 136.25,
        "duration": 2.07
    },
    {
        "text": "some independent research projects that I did",
        "start": 138.32,
        "duration": 1.9
    },
    {
        "text": "while at Merck that were not related to process chemistry.",
        "start": 140.22,
        "duration": 3.159
    },
    {
        "text": "So, I'm a process chemist full time,",
        "start": 143.379,
        "duration": 1.921
    },
    {
        "text": "but I do find some time in the day to develop new methods.",
        "start": 145.3,
        "duration": 3.71
    },
    {
        "text": "And really where this all started is",
        "start": 149.01,
        "duration": 1.14
    },
    {
        "text": "for the transformation shown here,",
        "start": 150.15,
        "duration": 1.62
    },
    {
        "text": "which is the conversion of electron portal aryl halides",
        "start": 151.77,
        "duration": 1.59
    },
    {
        "text": "to phenols.",
        "start": 153.36,
        "duration": 1.203
    },
    {
        "text": "And at first glance,",
        "start": 155.46,
        "duration": 0.833
    },
    {
        "text": "this looks like a trivial transformation.",
        "start": 156.293,
        "duration": 1.177
    },
    {
        "text": "You say, oh,",
        "start": 157.47,
        "duration": 0.833
    },
    {
        "text": "I can just take hydroxide and do SNAr to make the phenol,",
        "start": 158.303,
        "duration": 2.347
    },
    {
        "text": "but in reality that doesn't work.",
        "start": 160.65,
        "duration": 1.87
    },
    {
        "text": "Hydroxide is a poor nucleophile",
        "start": 162.52,
        "duration": 0.833
    },
    {
        "text": "and the products are often more reactive for SNAr.",
        "start": 163.353,
        "duration": 2.454
    },
    {
        "text": "So, you know, in my first year at Merck,",
        "start": 166.91,
        "duration": 2.72
    },
    {
        "text": "I started talking with a colleague of mine,",
        "start": 169.63,
        "duration": 2.91
    },
    {
        "text": "Kevin Maloney who was next door to my office.",
        "start": 172.54,
        "duration": 3.49
    },
    {
        "text": "And, you know, we shared a lot of common interests",
        "start": 176.03,
        "duration": 1.47
    },
    {
        "text": "and one of them was developing new methods",
        "start": 177.5,
        "duration": 1.84
    },
    {
        "text": "and we both thought that this would be",
        "start": 179.34,
        "duration": 1.69
    },
    {
        "text": "an interesting transformation.",
        "start": 181.03,
        "duration": 1.6
    },
    {
        "text": "And, you know, it's a long story,",
        "start": 182.63,
        "duration": 1.6
    },
    {
        "text": "but I'll cut to the punchline",
        "start": 184.23,
        "duration": 1.36
    },
    {
        "text": "is that we were able to develop",
        "start": 185.59,
        "duration": 1.52
    },
    {
        "text": "what we're terming these hydroxide surrogate ratings.",
        "start": 187.11,
        "duration": 1.92
    },
    {
        "text": "So, in this instance,",
        "start": 189.03,
        "duration": 1.61
    },
    {
        "text": "we developed reactions with acetohydroxamic acid,",
        "start": 190.64,
        "duration": 2.54
    },
    {
        "text": "out just under the box.",
        "start": 193.18,
        "duration": 1.22
    },
    {
        "text": "And this reacts under mildly basic conditions",
        "start": 194.4,
        "duration": 1.96
    },
    {
        "text": "because the OH bond is acidic",
        "start": 196.36,
        "duration": 1.4
    },
    {
        "text": "and the oxygen anion is an excellent nucleophile.",
        "start": 197.76,
        "duration": 2.43
    },
    {
        "text": "So, you can run these reactions under mild conditions,",
        "start": 200.19,
        "duration": 2.0
    },
    {
        "text": "the intermediate shown in the box,",
        "start": 202.19,
        "duration": 1.23
    },
    {
        "text": "then fragments itself under the same reaction conditions",
        "start": 203.42,
        "duration": 2.27
    },
    {
        "text": "through a loss and rearrangement so during these phenols.",
        "start": 205.69,
        "duration": 2.55
    },
    {
        "text": "So, that's Kevin there shown in the middle in the picture.",
        "start": 208.24,
        "duration": 3.6
    },
    {
        "text": "And we published this in 2016.",
        "start": 211.84,
        "duration": 0.833
    },
    {
        "text": "And it immediately took off internally,",
        "start": 212.673,
        "duration": 2.497
    },
    {
        "text": "which I'll get back to in a second.",
        "start": 215.17,
        "duration": 1.53
    },
    {
        "text": "There were some limitations of this of course,",
        "start": 216.7,
        "duration": 1.58
    },
    {
        "text": "you need an electron pore aryl halide coupling partner.",
        "start": 218.28,
        "duration": 3.68
    },
    {
        "text": "So, we wanted to expand this more broadly.",
        "start": 221.96,
        "duration": 1.26
    },
    {
        "text": "So we, we looked at palladium and copper catalyzed methods,",
        "start": 223.22,
        "duration": 2.39
    },
    {
        "text": "but there was issues with this reagents",
        "start": 225.61,
        "duration": 2.52
    },
    {
        "text": "over the sensitive activity.",
        "start": 228.13,
        "duration": 1.04
    },
    {
        "text": "And also the loss and rearrangement did not occur",
        "start": 229.17,
        "duration": 2.51
    },
    {
        "text": "unless the aromatic group has electron pores.",
        "start": 231.68,
        "duration": 2.253
    },
    {
        "text": "So, we went back to the drawing board",
        "start": 234.77,
        "duration": 1.62
    },
    {
        "text": "and we ultimately developed this",
        "start": 236.39,
        "duration": 0.89
    },
    {
        "text": "other hydroxide surrogate reaction",
        "start": 237.28,
        "duration": 2.59
    },
    {
        "text": "using benzaldehyde oxime.",
        "start": 239.87,
        "duration": 1.15
    },
    {
        "text": "We developed both palladium and copper-catalyzed methods",
        "start": 241.02,
        "duration": 2.52
    },
    {
        "text": "to allow for a really broad scope",
        "start": 243.54,
        "duration": 2.09
    },
    {
        "text": "for the conversion of, you know,",
        "start": 245.63,
        "duration": 1.37
    },
    {
        "text": "electronically and circularly diverse aryl halides",
        "start": 247.0,
        "duration": 2.525
    },
    {
        "text": "to phenols.",
        "start": 249.525,
        "duration": 0.833
    },
    {
        "text": "And we published two papers in 2017.",
        "start": 250.358,
        "duration": 1.525
    },
    {
        "text": "And, you know, really, you know,",
        "start": 253.05,
        "duration": 1.65
    },
    {
        "text": "what excites me about doing these side projects is",
        "start": 254.7,
        "duration": 2.43
    },
    {
        "text": "not only it's really fun to work with Kevin,",
        "start": 257.13,
        "duration": 1.71
    },
    {
        "text": "who's, you know, a great friend and colleague,",
        "start": 258.84,
        "duration": 1.9
    },
    {
        "text": "but the fact that this chemistry has been used extensively.",
        "start": 260.74,
        "duration": 3.6
    },
    {
        "text": "So, when I checked a few months ago,",
        "start": 264.34,
        "duration": 1.02
    },
    {
        "text": "this was used over 800 times at Merck so far",
        "start": 265.36,
        "duration": 2.91
    },
    {
        "text": "and it's used, you know,",
        "start": 268.27,
        "duration": 0.878
    },
    {
        "text": "on a daily basis, essentially.",
        "start": 269.148,
        "duration": 2.242
    },
    {
        "text": "It's also been used in a couple of cases on multi-kilo scale",
        "start": 271.39,
        "duration": 2.74
    },
    {
        "text": "for the supply of clinical material.",
        "start": 274.13,
        "duration": 2.27
    },
    {
        "text": "And it's routinely used across other pharm industries.",
        "start": 276.4,
        "duration": 2.51
    },
    {
        "text": "And it's also been used in a handful of cases",
        "start": 278.91,
        "duration": 3.62
    },
    {
        "text": "in the academic setting.",
        "start": 282.53,
        "duration": 1.02
    },
    {
        "text": "So for example,",
        "start": 283.55,
        "duration": 0.833
    },
    {
        "text": "the Illudinine Total Synthesis by Greg Dudley.",
        "start": 284.383,
        "duration": 3.387
    },
    {
        "text": "I won't read the text here,",
        "start": 287.77,
        "duration": 0.99
    },
    {
        "text": "but basically no other conditions work,",
        "start": 288.76,
        "duration": 1.67
    },
    {
        "text": "but our hydroxide surrogate strategy work.",
        "start": 290.43,
        "duration": 2.89
    },
    {
        "text": "And if you wanna hear more,",
        "start": 293.32,
        "duration": 0.833
    },
    {
        "text": "I'll refer you to episode two",
        "start": 294.153,
        "duration": 2.337
    },
    {
        "text": "of my colleague's Pharm to Table podcast.",
        "start": 296.49,
        "duration": 2.45
    },
    {
        "text": "So, this is a podcast put on by L.C. Campeau",
        "start": 298.94,
        "duration": 1.92
    },
    {
        "text": "who's in the left on the photo up top",
        "start": 300.86,
        "duration": 1.72
    },
    {
        "text": "and then Dani Schultz,",
        "start": 302.58,
        "duration": 1.08
    },
    {
        "text": "two excellent colleagues.",
        "start": 303.66,
        "duration": 0.89
    },
    {
        "text": "So, I encourage you to check out their podcast.",
        "start": 304.55,
        "duration": 2.35
    },
    {
        "text": "So, switching gears.",
        "start": 308.02,
        "duration": 2.14
    },
    {
        "text": "So, I mentioned in the introduction",
        "start": 310.16,
        "duration": 1.03
    },
    {
        "text": "that pyridines are extremely prevalent and as you know,",
        "start": 311.19,
        "duration": 2.44
    },
    {
        "text": "one of the most common heterocycles",
        "start": 313.63,
        "duration": 1.12
    },
    {
        "text": "in pharmaceutical chemistry.",
        "start": 314.75,
        "duration": 1.37
    },
    {
        "text": "So, in grad school I recognized this",
        "start": 316.12,
        "duration": 2.57
    },
    {
        "text": "and was interested in developing methods",
        "start": 318.69,
        "duration": 2.66
    },
    {
        "text": "for the selective functionalization of these.",
        "start": 321.35,
        "duration": 2.06
    },
    {
        "text": "So in 2013,",
        "start": 323.41,
        "duration": 1.26
    },
    {
        "text": "I developed this method for the fluorination of pyridines",
        "start": 324.67,
        "duration": 2.61
    },
    {
        "text": "using silver diamine fluoride.",
        "start": 327.28,
        "duration": 0.833
    },
    {
        "text": "And these reactions occurred with exquisite sites activity,",
        "start": 328.113,
        "duration": 2.067
    },
    {
        "text": "and, you know, really broad scope.",
        "start": 330.18,
        "duration": 1.59
    },
    {
        "text": "And the fluorinated products are okay as final products,",
        "start": 331.77,
        "duration": 3.13
    },
    {
        "text": "but they're really versatile synthetic intermediates,",
        "start": 334.9,
        "duration": 1.59
    },
    {
        "text": "where you can do SNAr with a variety of nuclear props.",
        "start": 336.49,
        "duration": 2.42
    },
    {
        "text": "And this chemistry is great,",
        "start": 338.91,
        "duration": 1.42
    },
    {
        "text": "but there are a few limitations, right?",
        "start": 340.33,
        "duration": 1.11
    },
    {
        "text": "Use of psychometric silver,",
        "start": 341.44,
        "duration": 1.41
    },
    {
        "text": "silver too is a strong oxidant, a strong Lewis acid.",
        "start": 342.85,
        "duration": 2.75
    },
    {
        "text": "So, there are some issues",
        "start": 345.6,
        "duration": 0.833
    },
    {
        "text": "with functional group compatibility.",
        "start": 346.433,
        "duration": 2.457
    },
    {
        "text": "So, when I came to Merck,",
        "start": 348.89,
        "duration": 2.73
    },
    {
        "text": "I was interested in developing",
        "start": 351.62,
        "duration": 2.15
    },
    {
        "text": "maybe a more process-friendly variant of this.",
        "start": 353.77,
        "duration": 3.76
    },
    {
        "text": "So, I built this bifunctional region,",
        "start": 357.53,
        "duration": 1.85
    },
    {
        "text": "which is shown in the box there.",
        "start": 359.38,
        "duration": 0.94
    },
    {
        "text": "This oxime derivative.",
        "start": 360.32,
        "duration": 2.88
    },
    {
        "text": "And the way this works is that",
        "start": 363.2,
        "duration": 1.01
    },
    {
        "text": "it reacts with pyridines to make this,",
        "start": 364.21,
        "duration": 1.86
    },
    {
        "text": "to make the electron-like pyridinium salt,",
        "start": 366.07,
        "duration": 2.09
    },
    {
        "text": "which is perinuclear condition.",
        "start": 368.16,
        "duration": 1.93
    },
    {
        "text": "And then that intermediate can undergo base mediated",
        "start": 370.09,
        "duration": 3.39
    },
    {
        "text": "re-aromatisation which reacts",
        "start": 374.81,
        "duration": 2.89
    },
    {
        "text": "via the loss of acetamide trial",
        "start": 377.7,
        "duration": 1.45
    },
    {
        "text": "and breaking the [inaudible] area of the sulfonate.",
        "start": 379.15,
        "duration": 2.53
    },
    {
        "text": "And these re-aromatizes your pyridine",
        "start": 381.68,
        "duration": 1.75
    },
    {
        "text": "to make these new compiled substitute pyridines.",
        "start": 383.43,
        "duration": 2.27
    },
    {
        "text": "And shortly after that,",
        "start": 385.7,
        "duration": 0.91
    },
    {
        "text": "this was commercialized by Sigma-Aldrich",
        "start": 386.61,
        "duration": 2.06
    },
    {
        "text": "and a few other vendors.",
        "start": 388.67,
        "duration": 1.48
    },
    {
        "text": "So, it's available for people around the world.",
        "start": 390.15,
        "duration": 2.98
    },
    {
        "text": "And it's chemistry was good.",
        "start": 393.13,
        "duration": 2.51
    },
    {
        "text": "It was, you know, interesting from a mechanistic,",
        "start": 395.64,
        "duration": 1.72
    },
    {
        "text": "mechanistic point of view,",
        "start": 397.36,
        "duration": 0.833
    },
    {
        "text": "but the substrate scope of the respect",
        "start": 398.193,
        "duration": 1.067
    },
    {
        "text": "of what nucleophile you can use was quite limited.",
        "start": 399.26,
        "duration": 2.2
    },
    {
        "text": "And it was primarily limited to things like cyanide,",
        "start": 401.46,
        "duration": 2.3
    },
    {
        "text": "for example.",
        "start": 403.76,
        "duration": 1.6
    },
    {
        "text": "So, I had a extremely talented intern",
        "start": 405.36,
        "duration": 4.4
    },
    {
        "text": "or he was a graduate student at the time, Suhong Kim.",
        "start": 409.76,
        "duration": 1.85
    },
    {
        "text": "Kevin worked with me for the Summer in 2019.",
        "start": 411.61,
        "duration": 3.35
    },
    {
        "text": "And we developed what we term \"The Aminator\",",
        "start": 414.96,
        "duration": 3.51
    },
    {
        "text": "which kind of addresses some of the function",
        "start": 418.47,
        "duration": 1.65
    },
    {
        "text": "compatibility issues in the previous paper.",
        "start": 420.12,
        "duration": 3.3
    },
    {
        "text": "So, this reagent is completely different,",
        "start": 423.42,
        "duration": 1.74
    },
    {
        "text": "but it works in a similar fashion.",
        "start": 425.16,
        "duration": 1.57
    },
    {
        "text": "That it activates the pyridine ring,",
        "start": 426.73,
        "duration": 1.82
    },
    {
        "text": "it has the two electron oxygen",
        "start": 428.55,
        "duration": 1.2
    },
    {
        "text": "and also delivers the nitrogen source.",
        "start": 429.75,
        "duration": 1.95
    },
    {
        "text": "So, I won't go into all the details or the mechanism.",
        "start": 431.7,
        "duration": 2.54
    },
    {
        "text": "I'll leave that up to the audience to figure out",
        "start": 434.24,
        "duration": 1.6
    },
    {
        "text": "or you can read this paper.",
        "start": 435.84,
        "duration": 1.983
    },
    {
        "text": "So again, switching gears to the third and final topic",
        "start": 439.58,
        "duration": 3.36
    },
    {
        "text": "of the independent research projects",
        "start": 442.94,
        "duration": 1.65
    },
    {
        "text": "is the late stage functionalizion of sulfonamides.",
        "start": 444.59,
        "duration": 3.13
    },
    {
        "text": "Of course, you know,",
        "start": 447.72,
        "duration": 0.833
    },
    {
        "text": "molecular editing is a buzzword these days,",
        "start": 448.553,
        "duration": 2.197
    },
    {
        "text": "so I think this really fits the bill.",
        "start": 450.75,
        "duration": 2.66
    },
    {
        "text": "So, you know, again,",
        "start": 453.41,
        "duration": 1.57
    },
    {
        "text": "Kevin and I were just chatting one day",
        "start": 454.98,
        "duration": 1.18
    },
    {
        "text": "and we're really interested in transformations,",
        "start": 456.16,
        "duration": 1.72
    },
    {
        "text": "such as the one shown here.",
        "start": 457.88,
        "duration": 1.0
    },
    {
        "text": "How can you take, for example,",
        "start": 458.88,
        "duration": 1.403
    },
    {
        "text": "a primary sulfonamide in some complex setting",
        "start": 460.283,
        "duration": 2.547
    },
    {
        "text": "that has multiple nitrogen heterocycles,",
        "start": 462.83,
        "duration": 1.72
    },
    {
        "text": "multiple, you know, basic functionality",
        "start": 464.55,
        "duration": 2.33
    },
    {
        "text": "and then selectively convert the NH2 group",
        "start": 466.88,
        "duration": 2.3
    },
    {
        "text": "of a primary sulfonamide to things like sulfones,",
        "start": 469.18,
        "duration": 2.263
    },
    {
        "text": "other sulfonamides, sulfonic acid",
        "start": 471.443,
        "duration": 1.234
    },
    {
        "text": "and so on and so forth.",
        "start": 472.677,
        "duration": 1.683
    },
    {
        "text": "So, of course this looks impossible on paper, but you know,",
        "start": 474.36,
        "duration": 3.39
    },
    {
        "text": "Kevin's an extremely creative guy and, you know, we,",
        "start": 477.75,
        "duration": 1.78
    },
    {
        "text": "we put our minds together and came up with,",
        "start": 479.53,
        "duration": 2.103
    },
    {
        "text": "what I think is a pretty interesting solution.",
        "start": 481.633,
        "duration": 3.667
    },
    {
        "text": "So, the general reaction mechanism shown here,",
        "start": 485.3,
        "duration": 1.91
    },
    {
        "text": "we're able to take primary sulfonamides",
        "start": 487.21,
        "duration": 1.244
    },
    {
        "text": "with benzaldehyde as a strict metric reductant.",
        "start": 488.454,
        "duration": 2.346
    },
    {
        "text": "You form these sulfinyl imines transiently in situ",
        "start": 490.8,
        "duration": 2.87
    },
    {
        "text": "and then C catalyst breaks these down",
        "start": 493.67,
        "duration": 2.67
    },
    {
        "text": "Foluso benzonitrile.",
        "start": 496.34,
        "duration": 1.204
    },
    {
        "text": "So, benzaldehyde oxides, benzonitrile",
        "start": 497.544,
        "duration": 2.034
    },
    {
        "text": "and your sulfonamides is reduced to a sulfonate,",
        "start": 499.578,
        "duration": 2.327
    },
    {
        "text": "out just under the box.",
        "start": 501.905,
        "duration": 1.195
    },
    {
        "text": "And once you have these sulfonates",
        "start": 503.1,
        "duration": 0.843
    },
    {
        "text": "that are extremely versatile intermediates",
        "start": 503.943,
        "duration": 2.534
    },
    {
        "text": "but can react with electrophiles",
        "start": 506.477,
        "duration": 0.833
    },
    {
        "text": "and your phenolic cross-couplings and so on and so forth.",
        "start": 507.31,
        "duration": 3.87
    },
    {
        "text": "So, through this pathway",
        "start": 511.18,
        "duration": 1.93
    },
    {
        "text": "we're able to do transformation such as the one shown here.",
        "start": 513.11,
        "duration": 2.3
    },
    {
        "text": "For example, on the left,",
        "start": 515.41,
        "duration": 0.833
    },
    {
        "text": "you can take this fairly complex sulfonamides",
        "start": 516.243,
        "duration": 2.367
    },
    {
        "text": "and selectively convert the NH2 group to a methyl group.",
        "start": 518.61,
        "duration": 3.12
    },
    {
        "text": "And in the right hand side,",
        "start": 521.73,
        "duration": 1.68
    },
    {
        "text": "you can take Celebrex and convert the NH2 group to,",
        "start": 523.41,
        "duration": 4.2
    },
    {
        "text": "for example, N15 NH2 for labeling,",
        "start": 527.61,
        "duration": 3.16
    },
    {
        "text": "which is important in drug discovery and development.",
        "start": 530.77,
        "duration": 2.19
    },
    {
        "text": "And you can also do transformation",
        "start": 532.96,
        "duration": 1.18
    },
    {
        "text": "that completely the removed the sulfonyl group",
        "start": 534.14,
        "duration": 2.67
    },
    {
        "text": "to generate, for example, bi-arrow compounds.",
        "start": 536.81,
        "duration": 2.16
    },
    {
        "text": "And this work was also scaled up to appreciable scale",
        "start": 538.97,
        "duration": 3.1
    },
    {
        "text": "and published in Organic Syntheses last year.",
        "start": 542.07,
        "duration": 3.053
    },
    {
        "text": "You know, so looking at this,",
        "start": 546.32,
        "duration": 1.39
    },
    {
        "text": "this initial paper was focused on primary sulfonamides,",
        "start": 547.71,
        "duration": 3.15
    },
    {
        "text": "but we want it to look more broadly.",
        "start": 550.86,
        "duration": 1.35
    },
    {
        "text": "How can we take, for example,",
        "start": 552.21,
        "duration": 1.35
    },
    {
        "text": "any secondary sulfonamides and selectively functionalize",
        "start": 553.56,
        "duration": 3.01
    },
    {
        "text": "any part of it that we want.",
        "start": 556.57,
        "duration": 1.35
    },
    {
        "text": "For example, switching the sulfur for a carbon",
        "start": 557.92,
        "duration": 2.61
    },
    {
        "text": "or cutting out nitrogen or switching any of the R-groups",
        "start": 560.53,
        "duration": 2.98
    },
    {
        "text": "in a late stage fashion.",
        "start": 563.51,
        "duration": 1.73
    },
    {
        "text": "And again, at the time this was completely unknown in it,",
        "start": 565.24,
        "duration": 1.557
    },
    {
        "text": "and it looks kind of silly on paper",
        "start": 566.797,
        "duration": 2.383
    },
    {
        "text": "that this would even be proposed.",
        "start": 569.18,
        "duration": 1.65
    },
    {
        "text": "But again, long story short,",
        "start": 572.3,
        "duration": 1.34
    },
    {
        "text": "and I'm cutting out some of the details",
        "start": 573.64,
        "duration": 1.48
    },
    {
        "text": "in the interest of time,",
        "start": 575.12,
        "duration": 1.03
    },
    {
        "text": "but we were able to develop conditions that allow for",
        "start": 576.15,
        "duration": 2.67
    },
    {
        "text": "transformation such as the one I just showed.",
        "start": 578.82,
        "duration": 2.1
    },
    {
        "text": "So, you can see here in the bottom left,",
        "start": 580.92,
        "duration": 1.46
    },
    {
        "text": "we can take this fairly complex sulfonamides",
        "start": 582.38,
        "duration": 2.78
    },
    {
        "text": "and convert it into an amide",
        "start": 585.16,
        "duration": 1.04
    },
    {
        "text": "by effectively replacing the SO2 group with a CO group.",
        "start": 586.2,
        "duration": 3.71
    },
    {
        "text": "And on the bottom right-hand side,",
        "start": 589.91,
        "duration": 1.16
    },
    {
        "text": "you can see that we take this and ethanesulfonamide",
        "start": 591.07,
        "duration": 2.03
    },
    {
        "text": "and convert it to a methylsulfonyl,",
        "start": 593.1,
        "duration": 1.63
    },
    {
        "text": "essentially excising nitrogen from a molecule.",
        "start": 594.73,
        "duration": 2.98
    },
    {
        "text": "And subtle changes like this",
        "start": 597.71,
        "duration": 0.9
    },
    {
        "text": "are important in drug discovery,",
        "start": 598.61,
        "duration": 1.16
    },
    {
        "text": "where you want to make minor tweaks",
        "start": 599.77,
        "duration": 1.87
    },
    {
        "text": "of a complex molecule to lead to new drug candidates.",
        "start": 601.64,
        "duration": 3.933
    },
    {
        "text": "All right.",
        "start": 607.77,
        "duration": 0.833
    },
    {
        "text": "So, that was some of the independent research",
        "start": 608.603,
        "duration": 1.757
    },
    {
        "text": "that I've done while at Merck,",
        "start": 610.36,
        "duration": 1.7
    },
    {
        "text": "predominantly with, you know,",
        "start": 612.06,
        "duration": 1.09
    },
    {
        "text": "my friend and colleague Kevin Maloney.",
        "start": 613.15,
        "duration": 1.99
    },
    {
        "text": "But of course I'm a process chemist by day.",
        "start": 615.14,
        "duration": 3.193
    },
    {
        "text": "And I was extremely honored",
        "start": 619.24,
        "duration": 1.39
    },
    {
        "text": "to have been selected to lead the efforts",
        "start": 620.63,
        "duration": 2.053
    },
    {
        "text": "for the process chemistry side for molnupiravir.",
        "start": 622.683,
        "duration": 2.707
    },
    {
        "text": "Which is internally known as MK-4482.",
        "start": 625.39,
        "duration": 2.54
    },
    {
        "text": "So, it's the compound shown on the top right,",
        "start": 627.93,
        "duration": 1.94
    },
    {
        "text": "this nucleoside derivative",
        "start": 629.87,
        "duration": 1.873
    },
    {
        "text": "and it's being investigated as,",
        "start": 631.743,
        "duration": 3.25
    },
    {
        "text": "it's being investigated as an antiviral for COVID-19.",
        "start": 634.993,
        "duration": 2.557
    },
    {
        "text": "This is an orally-dosed drug.",
        "start": 637.55,
        "duration": 1.69
    },
    {
        "text": "And the way it works is at the oxime functional group",
        "start": 639.24,
        "duration": 1.96
    },
    {
        "text": "on the heterocycle can switch between two tautomeric forms.",
        "start": 641.2,
        "duration": 3.44
    },
    {
        "text": "So, in the oxime form it can act like uridine.",
        "start": 644.64,
        "duration": 2.76
    },
    {
        "text": "And then the hydroxylamine form,",
        "start": 647.4,
        "duration": 1.77
    },
    {
        "text": "it can act like cytidine.",
        "start": 649.17,
        "duration": 1.19
    },
    {
        "text": "So in the RNA polymerase enzyme",
        "start": 650.36,
        "duration": 3.91
    },
    {
        "text": "this leads to viral error catastrophe",
        "start": 654.27,
        "duration": 1.7
    },
    {
        "text": "by causing all these mutations",
        "start": 655.97,
        "duration": 2.39
    },
    {
        "text": "and effectively killing the virus.",
        "start": 658.36,
        "duration": 1.54
    },
    {
        "text": "So, this is currently in phase III clinical trials.",
        "start": 659.9,
        "duration": 2.66
    },
    {
        "text": "The readout is expected imminently",
        "start": 662.56,
        "duration": 1.8
    },
    {
        "text": "within the next few weeks.",
        "start": 664.36,
        "duration": 1.29
    },
    {
        "text": "And the hope is that we would apply",
        "start": 665.65,
        "duration": 1.17
    },
    {
        "text": "for emergency use authorization before the end of the year.",
        "start": 666.82,
        "duration": 3.443
    },
    {
        "text": "And you know, this has been all over the news.",
        "start": 671.76,
        "duration": 1.7
    },
    {
        "text": "I'm sure, you know,",
        "start": 673.46,
        "duration": 0.833
    },
    {
        "text": "people have come across molnupiravir.",
        "start": 674.293,
        "duration": 1.357
    },
    {
        "text": "There was the headline on CNN.com yesterday,",
        "start": 675.65,
        "duration": 2.84
    },
    {
        "text": "was about this drug.",
        "start": 678.49,
        "duration": 1.95
    },
    {
        "text": "It's demonstrated very exciting antiviral activity",
        "start": 680.44,
        "duration": 3.54
    },
    {
        "text": "against SARS-CoV-2 in humans.",
        "start": 683.98,
        "duration": 2.22
    },
    {
        "text": "And it has, you know, really promising,",
        "start": 686.2,
        "duration": 2.523
    },
    {
        "text": "I guess it's very promising to help end the pandemic.",
        "start": 690.35,
        "duration": 2.65
    },
    {
        "text": "So, I won't go into all the details again",
        "start": 694.4,
        "duration": 2.77
    },
    {
        "text": "in the interest of time,",
        "start": 697.17,
        "duration": 1.19
    },
    {
        "text": "but there was two efforts for the molnupiravir team.",
        "start": 698.36,
        "duration": 2.31
    },
    {
        "text": "So, one of them was what we referred to as Gen 1",
        "start": 700.67,
        "duration": 3.16
    },
    {
        "text": "the first generation synthesis,",
        "start": 703.83,
        "duration": 1.65
    },
    {
        "text": "where we start from uridine",
        "start": 705.48,
        "duration": 1.56
    },
    {
        "text": "and there's a five-step synthesis",
        "start": 707.04,
        "duration": 1.28
    },
    {
        "text": "to convert it to molnupiravir.",
        "start": 708.32,
        "duration": 2.27
    },
    {
        "text": "So, we acquired a baseline process",
        "start": 710.59,
        "duration": 2.08
    },
    {
        "text": "when we partnered with Ridgeback",
        "start": 712.67,
        "duration": 2.18
    },
    {
        "text": "to develop this therapeutic.",
        "start": 714.85,
        "duration": 2.03
    },
    {
        "text": "And we had a few months to really improve the yields",
        "start": 716.88,
        "duration": 2.27
    },
    {
        "text": "and make it a robust process",
        "start": 719.15,
        "duration": 1.15
    },
    {
        "text": "so we can supply the world with this drug.",
        "start": 720.3,
        "duration": 2.93
    },
    {
        "text": "So again, I won't go into the details,",
        "start": 723.23,
        "duration": 1.64
    },
    {
        "text": "but over the five steps,",
        "start": 724.87,
        "duration": 1.58
    },
    {
        "text": "we were able to improve the yield by a factor of 1.6",
        "start": 726.45,
        "duration": 3.04
    },
    {
        "text": "and improve overall throughput and productivity",
        "start": 729.49,
        "duration": 2.95
    },
    {
        "text": "by a factor of two.",
        "start": 732.44,
        "duration": 1.06
    },
    {
        "text": "Meaning we can make twice as much material",
        "start": 733.5,
        "duration": 2.19
    },
    {
        "text": "as we would have otherwise.",
        "start": 735.69,
        "duration": 2.39
    },
    {
        "text": "So, this commercial process has been completed and validated",
        "start": 738.08,
        "duration": 3.84
    },
    {
        "text": "and implemented in five different countries.",
        "start": 741.92,
        "duration": 2.28
    },
    {
        "text": "To date, we made around 75,000 kilos of this drug,",
        "start": 744.2,
        "duration": 4.03
    },
    {
        "text": "which is around 350 million capsules",
        "start": 748.23,
        "duration": 2.1
    },
    {
        "text": "for the treatment of about 10 million people.",
        "start": 750.33,
        "duration": 2.94
    },
    {
        "text": "And this, this number is going up every day",
        "start": 753.27,
        "duration": 2.9
    },
    {
        "text": "about a metric ton per day on average.",
        "start": 756.17,
        "duration": 3.02
    },
    {
        "text": "And, you know we did a lot of improvements",
        "start": 759.19,
        "duration": 1.52
    },
    {
        "text": "as well to green chemistry,",
        "start": 760.71,
        "duration": 2.01
    },
    {
        "text": "you know, with,",
        "start": 762.72,
        "duration": 0.833
    },
    {
        "text": "with an eye towards green chemistry to prevent waste",
        "start": 763.553,
        "duration": 1.897
    },
    {
        "text": "and the improvements and the scale is done on meaning,",
        "start": 765.45,
        "duration": 3.76
    },
    {
        "text": "means that we're saving several millions",
        "start": 769.21,
        "duration": 2.03
    },
    {
        "text": "of kilos of waste each year.",
        "start": 771.24,
        "duration": 2.073
    },
    {
        "text": "And, you know,",
        "start": 774.21,
        "duration": 0.833
    },
    {
        "text": "this Gen 1 process is great,",
        "start": 775.043,
        "duration": 1.707
    },
    {
        "text": "it's what's used to supply the world,",
        "start": 776.75,
        "duration": 1.89
    },
    {
        "text": "but we also wanted to develop the ideal process.",
        "start": 778.64,
        "duration": 3.17
    },
    {
        "text": "So, the Gen 1 process starts from uridine",
        "start": 781.81,
        "duration": 2.37
    },
    {
        "text": "which is itself made from ribose and uracil .",
        "start": 784.18,
        "duration": 1.73
    },
    {
        "text": "So, we also came up with this",
        "start": 785.91,
        "duration": 2.226
    },
    {
        "text": "really short streamlined synthesis,",
        "start": 788.136,
        "duration": 1.814
    },
    {
        "text": "starting from ribose.",
        "start": 789.95,
        "duration": 1.75
    },
    {
        "text": "There's an enzymatic esterification",
        "start": 791.7,
        "duration": 1.59
    },
    {
        "text": "with isobutyric anhydride",
        "start": 793.29,
        "duration": 1.24
    },
    {
        "text": "to generate this non-isolated intermediate [inaudible]",
        "start": 794.53,
        "duration": 2.79
    },
    {
        "text": "and then a really elegant biocatalytic cascade",
        "start": 797.32,
        "duration": 2.36
    },
    {
        "text": "installs the uracil ring.",
        "start": 799.68,
        "duration": 1.34
    },
    {
        "text": "Generate this isobutyl uradine",
        "start": 801.02,
        "duration": 1.64
    },
    {
        "text": "intermediate as our only isolated intermediate.",
        "start": 802.66,
        "duration": 2.57
    },
    {
        "text": "And I really can't take credit for really any of this work.",
        "start": 805.23,
        "duration": 3.47
    },
    {
        "text": "This was done by my excellent colleagues",
        "start": 808.7,
        "duration": 2.2
    },
    {
        "text": "in the Biotalysis Merck Engineering Groups",
        "start": 810.9,
        "duration": 1.86
    },
    {
        "text": "to develop this extremely elegant cascade.",
        "start": 812.76,
        "duration": 2.55
    },
    {
        "text": "And I'm working with some process chemistry colleagues",
        "start": 815.31,
        "duration": 2.22
    },
    {
        "text": "to figure out isolation's and the process.",
        "start": 817.53,
        "duration": 2.55
    },
    {
        "text": "And in this final step",
        "start": 820.08,
        "duration": 0.86
    },
    {
        "text": "that is quite elegant dehydration method",
        "start": 820.94,
        "duration": 2.89
    },
    {
        "text": "developed primarily by my colleague, Steve Silverman,",
        "start": 823.83,
        "duration": 2.778
    },
    {
        "text": "to convert the carbonyl group into an oxime.",
        "start": 826.608,
        "duration": 2.602
    },
    {
        "text": "And this occurs in high yield using simple reagents.",
        "start": 829.21,
        "duration": 3.03
    },
    {
        "text": "So, overall compared to the baseline process",
        "start": 832.24,
        "duration": 1.84
    },
    {
        "text": "this is two-thirds fewer steps",
        "start": 834.08,
        "duration": 2.738
    },
    {
        "text": "and two-and-a-half fold higher yielding.",
        "start": 836.818,
        "duration": 2.242
    },
    {
        "text": "And it's approximately 50% cost of goods reduction.",
        "start": 839.06,
        "duration": 2.04
    },
    {
        "text": "And thank you Bethany for highlighting this work",
        "start": 841.1,
        "duration": 3.13
    },
    {
        "text": "earlier this year, and this,",
        "start": 844.23,
        "duration": 1.45
    },
    {
        "text": "this paper should be published imminently",
        "start": 845.68,
        "duration": 1.51
    },
    {
        "text": "in the next few days, so.",
        "start": 847.19,
        "duration": 1.893
    },
    {
        "text": "So, with that, I'll first thank all the colleagues",
        "start": 850.22,
        "duration": 3.12
    },
    {
        "text": "that I worked with for molnupiravir.",
        "start": 853.34,
        "duration": 1.33
    },
    {
        "text": "It's a very large team of chemists, engineers, alchemists",
        "start": 854.67,
        "duration": 2.93
    },
    {
        "text": "and so on and so forth.",
        "start": 857.6,
        "duration": 1.45
    },
    {
        "text": "These are, you know,",
        "start": 859.05,
        "duration": 1.38
    },
    {
        "text": "this wouldn't have been possible",
        "start": 860.43,
        "duration": 1.23
    },
    {
        "text": "without the team shown here.",
        "start": 861.66,
        "duration": 1.47
    },
    {
        "text": "And it's really amazing to have been able to",
        "start": 863.13,
        "duration": 2.073
    },
    {
        "text": "lead the process chemistry efforts",
        "start": 865.203,
        "duration": 1.497
    },
    {
        "text": "and work with these folks.",
        "start": 866.7,
        "duration": 2.15
    },
    {
        "text": "And then, you know, on a more personal note,",
        "start": 868.85,
        "duration": 2.08
    },
    {
        "text": "I'd like to thank the folks shown here.",
        "start": 870.93,
        "duration": 2.05
    },
    {
        "text": "So, Rebecca Green",
        "start": 872.98,
        "duration": 1.14
    },
    {
        "text": "my incredible wife who's dialed-in.",
        "start": 874.12,
        "duration": 2.19
    },
    {
        "text": "Hi, Rebecca.",
        "start": 876.31,
        "duration": 1.34
    },
    {
        "text": "Amazing person to partner with",
        "start": 877.65,
        "duration": 3.63
    },
    {
        "text": "and really amazing scientist.",
        "start": 881.28,
        "duration": 2.1
    },
    {
        "text": "Huge, thanks to John Hartwig, who I think is also online.",
        "start": 883.38,
        "duration": 2.3
    },
    {
        "text": "Hello, John.",
        "start": 885.68,
        "duration": 1.17
    },
    {
        "text": "Amazing mentor.",
        "start": 886.85,
        "duration": 1.39
    },
    {
        "text": "You know, he took this Iowa farm boy",
        "start": 888.24,
        "duration": 2.54
    },
    {
        "text": "and converted him into a scientist.",
        "start": 890.78,
        "duration": 1.4
    },
    {
        "text": "So thank you, John.",
        "start": 892.18,
        "duration": 0.88
    },
    {
        "text": "And my undergraduate advisor, Suhong Kim,",
        "start": 893.06,
        "duration": 2.38
    },
    {
        "text": "the co-inventor of \"Aminator\".",
        "start": 895.44,
        "duration": 1.81
    },
    {
        "text": "And Kevin,",
        "start": 897.25,
        "duration": 1.25
    },
    {
        "text": "who I've already mentioned many times",
        "start": 898.5,
        "duration": 1.64
    },
    {
        "text": "is an incredible friend and colleague.",
        "start": 900.14,
        "duration": 2.2
    },
    {
        "text": "And L.C. and you know,",
        "start": 902.34,
        "duration": 1.58
    },
    {
        "text": "the rest of the Merck leadership team,",
        "start": 903.92,
        "duration": 0.95
    },
    {
        "text": "not only for supporting these independent research projects,",
        "start": 904.87,
        "duration": 2.91
    },
    {
        "text": "but also for giving me the opportunity to lead",
        "start": 907.78,
        "duration": 1.91
    },
    {
        "text": "all the molnupirvir chemistry teams.",
        "start": 909.69,
        "duration": 1.94
    },
    {
        "text": "And of course,",
        "start": 911.63,
        "duration": 0.833
    },
    {
        "text": "thank you again to anyone who nominated me",
        "start": 912.463,
        "duration": 1.877
    },
    {
        "text": "and for selecting me for the Talented Twelve.",
        "start": 914.34,
        "duration": 2.17
    },
    {
        "text": "So, with that I'd be happy to answer any questions.",
        "start": 916.51,
        "duration": 2.55
    },
    {
        "text": "Thank you so much, Patrick.",
        "start": 920.21,
        "duration": 2.37
    },
    {
        "text": "As you pointed out,",
        "start": 922.58,
        "duration": 0.87
    },
    {
        "text": "I've been following the molnupirvir synthesis.",
        "start": 923.45,
        "duration": 3.01
    },
    {
        "text": "And I was just wondering if, you know,",
        "start": 926.46,
        "duration": 2.55
    },
    {
        "text": "there's any plans to move forward with the Gen 2 process?",
        "start": 929.01,
        "duration": 4.453
    },
    {
        "text": "Very good question. Yes.",
        "start": 934.91,
        "duration": 1.04
    },
    {
        "text": "So at, as of right now,",
        "start": 935.95,
        "duration": 2.69
    },
    {
        "text": "there are not, the plans.",
        "start": 938.64,
        "duration": 1.77
    },
    {
        "text": "Because we are committed to making",
        "start": 940.41,
        "duration": 1.93
    },
    {
        "text": "so much material with Gen 1",
        "start": 942.34,
        "duration": 1.01
    },
    {
        "text": "and we've already made so much.",
        "start": 943.35,
        "duration": 1.99
    },
    {
        "text": "That from the forecast it doesn't necessarily make sense.",
        "start": 945.34,
        "duration": 3.01
    },
    {
        "text": "But the pandemic is,",
        "start": 948.35,
        "duration": 2.32
    },
    {
        "text": "you can't predict it, right?",
        "start": 950.67,
        "duration": 1.09
    },
    {
        "text": "So, if demand goes up, if,",
        "start": 951.76,
        "duration": 3.07
    },
    {
        "text": "you know this really is going to be used heavily,",
        "start": 954.83,
        "duration": 2.55
    },
    {
        "text": "then there is the potential that we would revisit Gen 2.",
        "start": 957.38,
        "duration": 2.86
    },
    {
        "text": "So, we kind of parked it in a place",
        "start": 960.24,
        "duration": 2.24
    },
    {
        "text": "that is such that we could easily restart it",
        "start": 962.48,
        "duration": 2.52
    },
    {
        "text": "and validate it for commercial manufacturing.",
        "start": 965.0,
        "duration": 2.25
    },
    {
        "text": "Thank you so much.",
        "start": 968.29,
        "duration": 1.283
    },
    {
        "text": "(upbeat music)",
        "start": 971.781,
        "duration": 2.583
    }
]